Meyer Jaimie P, Womack Julie A, Gibson Britton
Yale School of Medicine, AIDS Program, New Haven, Connecticut.
Yale School of Nursing, West Haven, Connecticut; VA Connecticut Healthcare System, West Haven, Connecticut.
Yale J Biol Med. 2016 Jun 27;89(2):193-203. eCollection 2016 Jun.
Women comprise nearly one-quarter of all people living with human immunodeficiency virus (HIV) in the U.S. and 20 percent of incident annual cases. Though women overall are more likely than men to be diagnosed with HIV and engage in care, they are as unlikely to successfully achieve viral suppression with antiretroviral therapy, suggesting gender-based disparities that should be addressed by gender-responsive policies and programs. Using the socioecological model of health and syndemics theory, we comprehensively reviewed published literature to evaluate reasons for and ways to address gender differences in HIV risk and treatment. We discuss the biologic, sociocultural, interpersonal, and behavioral contexts of HIV risk that affect women, comprehensive healthcare for women with HIV that includes pregnancy planning or prevention, and policy implications.
在美国,感染人类免疫缺陷病毒(HIV)的人群中,女性占近四分之一,每年新增病例中女性占20%。尽管总体而言,女性比男性更易被诊断出感染HIV并接受治疗,但她们通过抗逆转录病毒疗法成功实现病毒抑制的可能性与男性相当,这表明存在基于性别的差异,需要通过针对性别的政策和项目加以解决。我们运用健康的社会生态模型和共病理论,全面回顾了已发表的文献,以评估HIV风险和治疗中性别差异的原因及解决方法。我们讨论了影响女性的HIV风险的生物学、社会文化、人际和行为背景、为感染HIV的女性提供的包括妊娠规划或预防在内的综合医疗保健,以及政策影响。